A 52 year old female suffering from severe progressive multiple sclerosis was administered quantifiable amounts of standardized cannabis and monitored over the period of one year, while providing daily pain charts and records of her condition. An average daily intake of 500 mg of Tetrahydrocannabinol as cannabis was required to achieve a desired quality of life. © 2010 Hornby and Sharma.
CITATION STYLE
Hornby, P., & Sharma, M. (2010). Standardized cannabis in multiple sclerosis: A case report. Cases Journal, 3(1). https://doi.org/10.1186/1757-1626-3-7
Mendeley helps you to discover research relevant for your work.